1 / 6

Is Ac-225-PSMA Therapy Safe ?

The most common side-effect of Targeted Alpha PSMA Therapy is dry mouth or Xerostomia and most patients do not report a very significant impact on their lifestyle.<br><br>For more info-<br>https://nuclearmedicinetherapy.in/treatments/alpha-psma-therapy

6676
Download Presentation

Is Ac-225-PSMA Therapy Safe ?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Ac-225-PSMA Therapy is a safe and tolerable treatment option for metastatic castration-resistant prostate cancer (mCRPC) patients who have been previously treated with chemotherapy. Trials and research have shown that significant improvement in survival and quality of life can be achieved even in patients with residual disease which otherwise have very limited options.

  2. The Department of Nuclear Medicine at Fortis Memorial Research Institute (FMRI), Gurugram, India, has treated more than 30 new patients of Castration Resistance Prostate Cancer (CRPC) with Ac225 PSMA Therapy. The results are extremely promising with 75-80% of patients showing evidences of significant radiological and biochemical response with prolonged duration of response.

  3. Alpha (Ac225) PSMA Therapy is an effective treatment modality for men with metastatic castration resistant prostate cancer (mCRPC). It helps improve quality of life by decreasing tumor growth rate and reducing pain.

  4. Research has shown that in men with metastatic castration-resistant prostate cancer who have progressed after conventional therapies, Lu177 PSMA Therapy not only has high response rates, low toxic effects, but most importantly reduced pain.

  5. Alpha PSMA Therapy has been proven effective for patients with advanced prostate cancer for whom surgical and other medical options have already exhausted themselves. They offer a new ray of hope. The Department of Nuclear Medicine at Fortis Memorial Research Institute (FMRI), Gurugram, India, has treated more than 30 new patients of Castration Resistance Prostate Cancer (CRPC) with Ac225 PSMA Therapy. The results are extremely promising with 75-80% of patients showing evidences of significant radiological and biochemical response with prolonged duration of response.

  6. For more information on the efficacy of Actinium 225 PSMA Therapy do call us at +91 98111 27080,or write to us at info@nuclearmedicinetherapy.in or visit https://nuclearmedicinetherapy.in/treatments/alpha-psma-therapy

More Related